Diseases of the outer eye in rheumatoid arthritis

被引:0
作者
Feist, E. [1 ]
Pleyer, U. [1 ]
机构
[1] Charite Univ Med Berlin, Augenklin, D-13353 Berlin, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2010年 / 69卷 / 05期
关键词
Rheumatoid arthritis; Eye involvement; Keratoconjunctivitis sicca; Episcleritis; Scleritis; Ulcerative keratitis; PERIPHERAL ULCERATIVE KERATITIS; NECROTIZING SCLERITIS; SYSTEMIC-DISEASE; THERAPY; CORNEAL; EPISCLERITIS; INFLIXIMAB; ASSOCIATION; ALPHA;
D O I
10.1007/s00393-009-0577-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Eye involvement is a frequent finding in patients with rheumatoid arthritis and may represent the leading clinical manifestation of disease. In this context, all components of the visual organ might be affected. The main spectrum of eye involvement comprises keratoconjunctivitis sicca, episcleritis and scleritis as well as ulcerative keratitis. As with the underlying disease, autoimmune reactions based on a patient's genetic predisposition are assumed to be of significance in disease pathogenesis. Emerging evidence also points to additional morphological and physiological ocular characteristics in the pathogenesis of the various ocular pathologies. This article gives an overview of clinical aspects, pathogenetic background as well as therapeutic options for ocular involvement in rheumatoid arthritis.
引用
收藏
页码:403 / +
页数:7
相关论文
共 32 条
[1]   Evaluation of patients with scleritis for systemic disease [J].
Akpek, EK ;
Thorne, JE ;
Qazi, FA ;
Do, DV ;
Jabs, DA .
OPHTHALMOLOGY, 2004, 111 (03) :501-506
[2]   Severity of episcleritis and systemic disease association [J].
Akpek, EK ;
Uy, HS ;
Christen, W ;
Gurdal, C ;
Foster, CS .
OPHTHALMOLOGY, 1999, 106 (04) :729-731
[3]   Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy [J].
Ashok, D ;
Ayliffe, WH ;
Kiely, PDW .
RHEUMATOLOGY, 2005, 44 (07) :950-951
[4]   Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab [J].
Atchia, Ismael I. ;
Kidd, C. Elizabeth ;
Bell, R. W. D. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2006, 12 (06) :291-293
[5]  
Baldassano V F Jr, 1998, Curr Opin Ophthalmol, V9, P85
[6]   Immunomodulatory therapy in ophthalmology - Is there a place for topical application? [J].
Bertelmann, E ;
Pleyer, U .
OPHTHALMOLOGICA, 2004, 218 (06) :359-367
[7]   Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases [J].
Botsios, C. ;
Sfriso, P. ;
Ostuni, P. A. ;
Todesco, S. ;
Punzi, L. .
RHEUMATOLOGY, 2007, 46 (06) :1042-1043
[8]   Rituximab for treatment of scleritis associated with rheumatoid arthritis [J].
Chauhan, S. ;
Kamal, A. ;
Thompson, R. N. ;
Estrach, C. ;
Moots, R. J. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (07) :984-985
[9]  
de la Maza MS, 2002, ARCH OPHTHALMOL-CHIC, V120, P15
[10]  
DELAMAZA MS, 1994, OPHTHALMOLOGY, V101, P1281